Correction: Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations
Nadera Sweiss(University of Illinois Chicago), Timothy B. Niewold(Hospital for Special Surgery), Rafah Salloum(University of Chicago), Maria‐Luisa Alegre(University of Chicago), Robert P. Baughman(University of Cincinnati), Seema Gandhi(John H. Stroger, Jr. Hospital of Cook County), Joe G. N. Garcia(Scripps Research Institute), Maria Badaracco(University of Chicago), David Pitrak(University of Chicago), Kenneth Pursell(University of Chicago), Ray Sawaqed(Methodist Hospital), David R. Möller(Johns Hopkins University)
Cited by 21
Related Papers
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503